Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-tumor pharmaceutical composition

A composition and anti-tumor technology, applied in the field of biomedicine

Inactive Publication Date: 2015-04-08
JINAN XINGYI MEDICAL TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, Chinese herbal medicine has not become the first choice of anticancer drugs at home and abroad, and the anticancer efficacy of existing clinical Chinese herbal medicines needs to be further improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-tumor pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: antitumor pharmaceutical composition

[0024] The composition and parts by weight of the crude drug of the antitumor pharmaceutical composition are:

[0025] 11 parts by weight of gomisin G, 28 parts by weight of hematin, 10 parts by weight of solanine, and 40 parts by weight of glucoraphanin.

Embodiment 2

[0026] Embodiment 2: antitumor pharmaceutical composition

[0027] The composition and parts by weight of the crude drug of the antitumor pharmaceutical composition are:

[0028] 33 parts by weight of gomisin G, 16 parts by weight of hematin, 25 parts by weight of solanine, and 30 parts by weight of glucoraphanin.

Embodiment 3

[0029] Embodiment 3: antitumor pharmaceutical composition

[0030] The composition and parts by weight of the crude drug of the antitumor pharmaceutical composition are:

[0031] 22 parts by weight of gomisin G, 20 parts by weight of hematin, 17 parts by weight of solanine, and 35 parts by weight of glucoraphanin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an anti-tumor pharmaceutical composition, which takes gomisin G, dracorubin, solasonine and glucoraphanin as raw materials through preparation ratio, various dosage forms can be prepared by a conventional preparation technology, and the anti-tumor pharmaceutical composition has important meaning for preparing the anti-liver cancer, anti-lung cancer and anti-stomach cancer drugs.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to an antitumor pharmaceutical composition. Background technique [0002] According to statistics from the Ministry of Health in February 2010, the number of cancer deaths worldwide reaches 10 million each year. At present, one-quarter of the global population's death is caused by cancer, and it is predicted that if the current trend continues, one-half of the deaths will be due to cancer by 2050. The incidence of malignant cancer in my country is increasing at a rate of 2.5-5% per year, and it has become the culprit that seriously endangers human life. Among various types of cancer, lung cancer, gastric cancer, and liver cancer have higher incidence rates. [0003] Blood vessels are necessary for the formation and function maintenance of normal tissues and organs, and are closely related to human developmental disorders and various diseases caused by various causes. Tumor neovascularizat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/706A61P35/00A61K31/357A61K31/352A61K31/7028
CPCA61K31/706A61K9/0053A61K9/2031A61K9/2059A61K9/4866A61K31/352A61K31/357A61K31/7028A61K2300/00
Inventor 孔倩倩
Owner JINAN XINGYI MEDICAL TECH